nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity
|
Ahlgren, J |
|
2002 |
38 |
1 |
p. 64-69 6 p. |
artikel |
2 |
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer
|
Gore, M |
|
2002 |
38 |
1 |
p. 57-63 7 p. |
artikel |
3 |
Carboplatin dosing
|
Dooley, M.J |
|
2002 |
38 |
1 |
p. 44-51 8 p. |
artikel |
4 |
Carboplatin dosing formulae
|
Calvert, A.H |
|
2002 |
38 |
1 |
p. 11-16 6 p. |
artikel |
5 |
Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA
|
Eppler, E |
|
2002 |
38 |
1 |
p. 184-193 10 p. |
artikel |
6 |
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification
|
Kim, K |
|
2002 |
38 |
1 |
p. 75-81 7 p. |
artikel |
7 |
ECCO 11—the European Cancer Conference, Lisbon, Portugal, 21–25 October 2001
|
|
|
2002 |
38 |
1 |
p. 1-5 5 p. |
artikel |
8 |
Estimates of cancer incidence and mortality in Europe in 1995
|
Bray, F |
|
2002 |
38 |
1 |
p. 99-166 68 p. |
artikel |
9 |
Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system
|
Eggert, A |
|
2002 |
38 |
1 |
p. 92-98 7 p. |
artikel |
10 |
Fatigue in cancer patients during and after treatment
|
Servaes, P |
|
2002 |
38 |
1 |
p. 27-43 17 p. |
artikel |
11 |
FECS 20th Birthday—A survivor speaks
|
Horiot, Jean-Claude |
|
2002 |
38 |
1 |
p. 8-10 3 p. |
artikel |
12 |
Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing
|
Léger, F. |
|
2002 |
38 |
1 |
p. 52-56 5 p. |
artikel |
13 |
In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine
|
Nicholson, K.M |
|
2002 |
38 |
1 |
p. 194-204 11 p. |
artikel |
14 |
Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma
|
Zuzak, T.J. |
|
2002 |
38 |
1 |
p. 83-91 9 p. |
artikel |
15 |
Modulation of cisplatin pharmacodynamics by Cremophor EL
|
Gelderblom, H |
|
2002 |
38 |
1 |
p. 205-213 9 p. |
artikel |
16 |
[No title]
|
D'Incalci, Dr.M |
|
2002 |
38 |
1 |
p. 17- 1 p. |
artikel |
17 |
[No title]
|
Smyth, J.F |
|
2002 |
38 |
1 |
p. 7- 1 p. |
artikel |
18 |
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer
|
Caponigro, F |
|
2002 |
38 |
1 |
p. 70-74 5 p. |
artikel |
19 |
Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil
|
Mizutani, Y |
|
2002 |
38 |
1 |
p. 167-176 10 p. |
artikel |
20 |
Quality control in prophylactic mastectomy for women at high risk of breast cancer
|
Petit, J.Y. |
|
2002 |
38 |
1 |
p. 23-26 4 p. |
artikel |
21 |
The use of oral cytotoxic and cytostatic drugs in cancer treatment
|
Sparreboom, A |
|
2002 |
38 |
1 |
p. 18-22 5 p. |
artikel |
22 |
This issue's topics
|
|
|
2002 |
38 |
1 |
p. ix- 1 p. |
artikel |
23 |
Trail activity in human ovarian cancer cells
|
Vignati, S |
|
2002 |
38 |
1 |
p. 177-183 7 p. |
artikel |